While various studies have suggested that TRAIL-R2 upregulation might contribute to synergistic cell death responses of cancer cells upon combined ER stress and TRAIL treatment, TRAIL-R2 has also been implicated in promoting ER stress-induced apoptosis independent of its role as a cell surface death receptor [22]. Here, TNFRSF10B is linked to cancer.